Amedisys, Inc.
AMED
Rank in Stocks
#4615
Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of... Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of healthcare solutions throughout the United States. Its operations are structured across four distinct divisions: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment furnishes a diverse array of services provided within individuals' residences. These services support patients in their recovery from surgeries, chronic ailments, or serious illnesses, and also aim to minimize preventable hospital readmissions. This is achieved through its team of proficient nurses, rehabilitation therapists specializing in physical, speech, and occupational therapy, as well as social workers and care assistants who support patients. The Hospice division is dedicated to offering comfort and empathetic support to those facing a terminal illness, encompassing conditions like cancer, heart disease, pulmonary disease, or Alzheimer's. Within the Personal Care segment, patients receive assistance with their routine daily activities. Finally, the High Acuity Care segment extends crucial elements of inpatient hospital care, skilled nursing facility services, and palliative care directly to patients within their own homes. As of December 31, 2021, the company maintained a network comprising 331 home health centers, 175 hospice care centers, 14 personal-care facilities, and 8 high acuity care centers. These facilities are situated across 38 states in the U.S. and the District of Columbia. Amedisys, Inc. was established in 1982 and its principal executive offices are located in Baton Rouge, Louisiana.
Share Price
$100.99
Last synced: 2025-08-15
Market Cap
$3.31B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Amedisys, Inc. (AMED)
Category
Healthcare
Revenue for Amedisys, Inc. (AMED)
Revenue in Jun 2025 TTM: $2.40B
According to Amedisys, Inc. latest financial reports the company's current revenue (TTM) is $2.40B. In 2023 the company made a revenue of $2.24B an increase over the revenue in the year 2022 that was $2.22B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Amedisys, Inc. from 2000 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $2.40B | 2.30% |
| 2024 | $2.35B | 5.01% |
| 2023 | $2.24B | 0.59% |
| 2022 | $2.22B | 0.41% |
| 2021 | $2.21B | 6.88% |
| 2020 | $2.07B | 5.93% |
| 2019 | $1.96B | 17.63% |
| 2018 | $1.66B | 8.40% |
| 2017 | $1.53B | 6.69% |
| 2016 | $1.44B | 12.25% |
| 2015 | $1.28B | 6.31% |
| 2014 | $1.20B | -3.59% |
| 2013 | $1.25B | -16.03% |
| 2012 | $1.49B | 1.19% |
| 2011 | $1.47B | -10.03% |
| 2010 | $1.63B | 7.99% |
| 2009 | $1.51B | 27.46% |
| 2008 | $1.19B | 70.13% |
| 2007 | $697.93M | 28.97% |
| 2006 | $541.15M | 41.83% |
| 2005 | $381.56M | 68.02% |
| 2004 | $227.09M | 59.39% |
| 2003 | $142.47M | 10.08% |
| 2002 | $129.42M | 17.47% |
| 2001 | $110.17M | 21.40% |
| 2000 | $90.76M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $78.01B | 3,147.34% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 807.94% |
US
|
|
| $3.89B | 62.13% |
SA
|
|
| $11.08B | 361.42% |
BR
|
